Placebo to PF-07275315, PF-07275315 clinical trials

C4531031 - AN INTERVENTIONAL PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, THIRD PARTY-UNBLINDED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF PF-07275315 IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

This study is testing a new medicine called PF-07275315 for adults with moderate to severe COPD. We want to see if it helps improve breathing and reduces flare-ups, compared to a dummy medicine.